Doximity, Inc. $DOCS Shares Bought by Prudential PLC

Prudential PLC grew its holdings in shares of Doximity, Inc. (NYSE:DOCS) by 78.8% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 95,138 shares of the company’s stock after purchasing an additional 41,930 shares during the period. Prudential PLC’s holdings in Doximity were worth $4,213,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently modified their holdings of the company. Atlantic Union Bankshares Corp raised its holdings in shares of Doximity by 136.9% during the third quarter. Atlantic Union Bankshares Corp now owns 616 shares of the company’s stock worth $45,000 after purchasing an additional 356 shares during the period. Northwestern Mutual Wealth Management Co. raised its holdings in shares of Doximity by 99.5% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 796 shares of the company’s stock worth $35,000 after purchasing an additional 397 shares during the period. Toth Financial Advisory Corp raised its holdings in shares of Doximity by 100.0% during the fourth quarter. Toth Financial Advisory Corp now owns 1,000 shares of the company’s stock worth $44,000 after purchasing an additional 500 shares during the period. Hantz Financial Services Inc. raised its holdings in shares of Doximity by 221.0% during the third quarter. Hantz Financial Services Inc. now owns 1,454 shares of the company’s stock worth $106,000 after purchasing an additional 1,001 shares during the period. Finally, Advisory Services Network LLC acquired a new stake in shares of Doximity during the third quarter worth $111,000. 87.19% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on the stock. Loop Capital set a $31.00 target price on shares of Doximity in a report on Tuesday, March 17th. JPMorgan Chase & Co. dropped their price objective on shares of Doximity from $33.00 to $28.00 and set a “neutral” rating on the stock in a report on Thursday, May 14th. Evercore cut shares of Doximity from an “outperform” rating to an “in-line” rating and set a $25.00 price objective on the stock. in a report on Wednesday, April 8th. Canaccord Genuity Group dropped their price objective on shares of Doximity from $34.00 to $30.00 and set a “buy” rating on the stock in a report on Thursday, May 14th. Finally, Leerink Partners dropped their price objective on shares of Doximity from $31.00 to $25.00 and set an “outperform” rating on the stock in a report on Thursday, May 14th. Two equities research analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating, twelve have given a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $30.62.

Doximity Stock Performance

DOCS stock opened at $20.56 on Friday. Doximity, Inc. has a fifty-two week low of $17.15 and a fifty-two week high of $76.51. The business has a 50-day moving average price of $22.64. The firm has a market cap of $3.76 billion, a PE ratio of 20.77, a PEG ratio of 3.50 and a beta of 1.30.

Insider Transactions at Doximity

In related news, Director Kira Scherer Wampler sold 9,000 shares of the stock in a transaction dated Thursday, May 7th. The shares were sold at an average price of $26.06, for a total value of $234,540.00. Following the sale, the director owned 19,839 shares of the company’s stock, valued at $517,004.34. This trade represents a 31.21% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Siddharth Sitaram sold 2,309 shares of the stock in a transaction dated Monday, May 11th. The shares were sold at an average price of $25.77, for a total transaction of $59,502.93. Following the completion of the transaction, the insider owned 89,396 shares of the company’s stock, valued at $2,303,734.92. This represents a 2.52% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last ninety days, insiders sold 16,055 shares of company stock worth $404,061. Corporate insiders own 31.30% of the company’s stock.

Doximity Profile

Doximity, trading as DOCS, operates a digital professional network and communications platform designed primarily for clinicians. Headquartered in San Francisco, the company connects physicians, nurse practitioners, physician assistants and other healthcare professionals, providing tools that streamline clinical communication, telehealth delivery and access to specialty-specific medical information. Its platform is positioned as a professional hub where clinicians manage their workflows, stay current with medical news and collaborate securely with peers.

The company’s offerings include secure messaging and video telehealth capabilities that enable clinicians to consult with patients and colleagues while protecting patient information.